New Product Newswire
FDA Grants Clearance to twiist Automated Insulin Delivery System for T1D
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Resmetirom as First-Ever Treatment For MASH
The approval, awarded to Madrigal Pharmaceuticals, was based on phase 3 data demonstrating that resmetirom achieved broad treatment effects in patients with MASH with liver fibrosis.
Breaking: FDA Approves Wegovy to Reduce Cardiovascular Risks in Overweight, Obesity
Study results demonstrated the efficacy of semaglutide (Wegovy) in reducing cardiovascular risks in adults with overweight or obesity without diabetes.
FDA Approves Nivolumab Plus Chemotherapy for Unresectable or Metastatic Urothelial Carcinoma
A clinical trial showed that nivolumab plus chemotherapy significantly improved overall survival and progression-free survival compared with a chemotherapy combination alone.
FDA Grants Accelerated Approval to Zanubrutinib for R/R Follicular Lymphoma
This is the fifth oncology indication for zanubrutinib in the United States.